articleTop 1% cited
Characterization of a Novel Endocannabinoid, Virodhamine, with Antagonist Activity at the CB1 Receptor
Journal of Pharmacology and Experimental Therapeutics · 2002 · Vol. 301(3) · pp. 1020–1024
Amy C. Porter✉(Eli Lilly (United States))John‐Michael SauerMichael D. KniermanGerald W. BeckerMichael J. BernaJingqi BaoGeorge G. NomikosPetra CarterFrank P. BymasterAndrea Baker LeeseChristian C. Felder
Cannabis and Cannabinoid ResearchForensic Toxicology and Drug AnalysisNeuroscience of respiration and sleepAnandamideCannabinoid receptorEndocannabinoid systemDepolarization-induced suppression of inhibitionCannabinoidChemistryAgonistAntagonistPharmacologyCannabinoid receptor type 2
MeSH terms
AnimalsArachidonic AcidsBody TemperatureBrainCannabinoidsDose-Response Relationship, DrugHippocampusMaleReceptors, DrugRats, WistarEthanolamineReceptors, CannabinoidReceptor, Cannabinoid, CB2MiceRats
Citations
609
FWCI
28.38
field-weighted impact
References
16
Percentile
100%
vs. same field & year
Citations per year
Cited by
Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures — A short review
Pharmacology Biochemistry and Behavior · 2008 · 455 citations
The pharmacology of cannabinoid receptors and their ligands: an overview
International Journal of Obesity · 2006 · 550 citations
Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain
Brain Research · 2006 · 804 citations
The molecular logic of endocannabinoid signalling
Nature reviews. Neuroscience · 2003 · 1,925 citations
References
Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
Biochemical Pharmacology · 1995 · 2,893 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.